Cagent Vascular

Cagent Vascular develops and commercializes Serration Angioplasty Technology, a transformative improvement to conventional angioplasty for treating peripheral artery disease (PAD). Their Serranator device offers greater lumen gain and reduced elastic recoil compared to plain angioplasty balloons, leading to improved blood flow and patient outcomes. The company focuses on providing greater access to this innovative technology for healthcare providers and their patients.

Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $30M

Date: 20-Feb-2024

Investors: U.S. Venture Partners (USVP), Blue Ridge Medical, LLC, Sectoral Asset Management

Markets: Medtech, Cardiovascular, Medical Equipment Manufacturing, Health Care, Medical, Medical Device

HQ: Wayne, Pennsylvania, United States

Founded: 2014

Website: https://www.cagentvascular.com/

LinkedIn: https://www.linkedin.com/company/cagent-vascular

Twitter: https://twitter.com/cagentvascular

Instagram: